Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
Abstract:
Methods for formulating and compositions of immediate and sustained release liposomal products which comprise a surfactant that interacts with liposomes to effect drug release therefrom, and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
Information query
Patent Agency Ranking
0/0